The General Abstract Submission Portal is now closed.

Late-Breaking Abstract Submissions can be submitted here.  

Please open this webpage in Google Chrome or Mozilla Firefox for the best user experience.

Abstract Submission Guidelines:

• Oral presentations will be selected from abstracts submitted by the December 31, 2021 deadline. We request those not selected for oral presentations to present their poster as part of the in-person and virtual poster sessions.
• The first author (presenting author) will receive all future correspondence from MDA regarding the abstract.  
• Abstract titles should be 150 characters including spaces. Abstract body should not exceed 300 words. 
• Authors may submit abstracts on the following topics in neuromuscular disease (NMD) research and care:
  • Pre-Clinical Research
  • Translational Research
  • Clinical Trials 
  • Clinical Management 
  • Other

2022 MDA Embargo Policy

All abstracts accepted for the 2022 MDA Clinical & Scientific Conference will be available in the Abstract Library starting Monday, February 28, 2022. 

While authors may publish that their poster has been selected for inclusion in the conference program, data from the final poster presentation may not be shared in any form (print, broadcast or online publication, media release or conference presentation) prior to its official presentation at MDA Conference 2022 which will be Sunday, March 13, 2022 6:00PM CST. Author(s) retains copyright of his or her abstract and poster.

Encores are permitted provided that: (i) copyright requirements from the initial conference are respected and (ii) prior presentations are disclosed.

Questions about the abstract submission process or poster session guidelines, please contact 2022mdaconference@mdausa.org.